Michael J. Valentino

Michael J. Valentino is an Independent Director.

Michael has spent 30+ years as a healthcare industry executive. He built the start-up Adams Respiratory Therapeutics into a fully integrated specialty pharmaceutical company with more than $400 million in annual revenue. Adams completed its initial public offering (IPO) in July 2005, which was ranked by The Wall Street Journal as the No. 1 Health Care IPO in 2005. In 2007, Reckitt Benckiser, a world leader in household products, acquired Adams for $2.3 billion.

Michael served as President, CEO, and Chairman of the Board of Directors for Xanodyne Pharmaceuticals, Inc., and President and Chief Operating Officer at Alpharma, Inc., a leading global generic pharmaceutical company. Additionally, he served as Executive Vice President, Global Head Consumer Pharmaceuticals for Novartis, President and Chief Operating Officer of Novartis Consumer Healthcare, North America, and President of Pharmacia & Upjohn's Consumer Products.

Michael J. Valentino is the Chairman of the Board at UrgentRx, based in United States, North America. With a background in Health Care, Michael J. Valentino has a rich history of leadership and innovation.Michael J. Valentino studied BA Psychology at Stony Brook University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.